Catalyst Wire Dossier Catalyst Wire Dossier

Lemvemir

insulin detemir · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lemvemir, covering 2021-07-13 to 2021-07-13. Get the full timeline:

Most recent: EMA Authorised: Levemir (Insulin detemir) — Novo Nordisk A/S

See pricing